VA
VR Adviser’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.3M | Hold |
3,882,709
| – | – | 4.07% | 7 |
|
|
2025
Q1 | $52.3M | Hold |
3,882,709
| – | – | 4.45% | 6 |
|
|
2024
Q4 | $74.4M | Hold |
3,882,709
| – | – | 5.11% | 5 |
|
|
2024
Q3 | $88.3M | Buy |
3,882,709
+38
| +0% | +$865 | 4.63% | 4 |
|
|
2024
Q2 | $50.5M | Hold |
3,882,671
| – | – | 3.22% | 11 |
|
|
2024
Q1 | $68M | Buy |
3,882,671
+48
| +0% | +$840 | 3.23% | 9 |
|
|
2023
Q4 | $84.6M | Buy |
3,882,623
+800,001
| +26% | +$17.4M | 5.8% | 4 |
|
|
2023
Q3 | $47.3M | Hold |
3,082,622
| – | – | 4.98% | 3 |
|
|
2023
Q2 | $73.3M | Buy |
3,082,622
+382,757
| +14% | +$9.11M | 11.73% | 1 |
|
|
2023
Q1 | $68.7M | Hold |
2,699,865
| – | – | 13.41% | 1 |
|
|
2022
Q4 | $78.9M | Buy |
2,699,865
+569,557
| +27% | +$16.6M | 13.29% | 1 |
|
|
2022
Q3 | $43.7M | Buy |
2,130,308
+277,389
| +15% | +$5.69M | 6.74% | 5 |
|
|
2022
Q2 | $21.4M | Hold |
1,852,919
| – | – | 4.22% | 9 |
|
|
2022
Q1 | $34.3M | Hold |
1,852,919
| – | – | 5.55% | 7 |
|
|
2021
Q4 | $36.6M | Buy |
1,852,919
+1,833,424
| +9,405% | +$36.2M | 5.01% | 7 |
|
|
2021
Q3 | $321K | Hold |
19,495
| – | – | 0.04% | 26 |
|
|
2021
Q2 | $357K | Hold |
19,495
| – | – | 0.04% | 29 |
|
|
2021
Q1 | $326K | Hold |
19,495
| – | – | 0.04% | 28 |
|
|
2020
Q4 | $321K | Buy |
+19,495
| New | +$321K | 0.05% | 25 |
|